MV

Muniraj Venkatesan

Active Director Designated Partner DIN 08415973
DIN 08415973 First appointment Apr 2019 Primary industry Life Sciences
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2019
Shareholding value β€’β€’β€’β€’ Premium profile

About Muniraj Venkatesan

Data last updated:

Muniraj Venkatesan is a Designated Partner at Illume Gene India Llp (since 2019). The company operates in Life Sciences.

DIN 08415973
Primary Designation Designated Partner
Industry Life Sciences
First Appointment 08 Apr 2019
Oldest Company Age 7 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner08 Apr 20192019Active

Board colleagues of Muniraj Venkatesan

NameDINCompanyDesignation
Egambaram Selvakumar08360479Illume Gene India LlpDesignated Partner
Rohit Vikash08360478Illume Gene India LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Illume Gene India Llp
Premium access

Shareholding and investment profile for Muniraj Venkatesan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Muniraj Venkatesan

Muniraj Venkatesan currently holds 1 directorship: Illume Gene India Llp (Designated Partner, since 08 Apr 2019).

Muniraj Venkatesan was first appointed on 08 Apr 2019 as Designated Partner at Illume Gene India Llp.

The current boards of Muniraj Venkatesan's companies include Egambaram Selvakumar (Illume Gene India Llp), Rohit Vikash (Illume Gene India Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available